SP4
Basic information
Region (hg38): 7:21428043-21514822
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SP4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 43 | 46 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 45 | 2 | 1 |
Variants in SP4
This is a list of pathogenic ClinVar variants found in the SP4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-21428701-A-C | not specified | Uncertain significance (Nov 10, 2022) | ||
7-21428754-G-A | not specified | Uncertain significance (Aug 22, 2023) | ||
7-21428754-G-C | not specified | Uncertain significance (May 23, 2023) | ||
7-21428758-A-AT | 6 conditions | Uncertain significance (Mar 24, 2023) | ||
7-21428764-A-G | not specified | Uncertain significance (May 24, 2024) | ||
7-21429423-A-T | not specified | Uncertain significance (Jun 29, 2022) | ||
7-21429442-G-T | not specified | Uncertain significance (Jun 28, 2022) | ||
7-21429484-T-A | not specified | Uncertain significance (May 17, 2023) | ||
7-21429491-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
7-21429527-C-T | not specified | Uncertain significance (May 17, 2023) | ||
7-21429536-C-T | not specified | Uncertain significance (Apr 14, 2022) | ||
7-21429568-G-A | not specified | Uncertain significance (Apr 19, 2023) | ||
7-21429588-AT-A | Uncertain significance (Sep 20, 2022) | |||
7-21429601-T-C | not specified | Uncertain significance (Nov 06, 2023) | ||
7-21429602-C-T | not specified | Uncertain significance (Nov 06, 2023) | ||
7-21429608-C-G | not specified | Uncertain significance (Jan 12, 2024) | ||
7-21429610-G-C | not specified | Uncertain significance (May 08, 2023) | ||
7-21429646-G-A | not specified | Uncertain significance (Aug 08, 2022) | ||
7-21429670-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
7-21429793-G-A | not specified | Uncertain significance (May 02, 2024) | ||
7-21429874-G-A | not specified | Uncertain significance (Jun 29, 2022) | ||
7-21429886-C-G | Benign (Jul 30, 2018) | |||
7-21429896-A-T | not specified | Uncertain significance (Mar 18, 2024) | ||
7-21429910-A-G | not specified | Uncertain significance (Dec 19, 2022) | ||
7-21429925-G-C | not specified | Uncertain significance (Dec 30, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SP4 | protein_coding | protein_coding | ENST00000222584 | 6 | 86789 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.993 | 0.00712 | 125735 | 0 | 13 | 125748 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.395 | 386 | 408 | 0.945 | 0.0000200 | 5058 |
Missense in Polyphen | 85 | 137.87 | 0.61653 | 1754 | ||
Synonymous | -0.738 | 164 | 152 | 1.08 | 0.00000826 | 1661 |
Loss of Function | 4.62 | 4 | 32.4 | 0.123 | 0.00000157 | 336 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000935 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000616 | 0.0000615 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Binds to GT and GC boxes promoters elements. Probable transcriptional activator.;
Recessive Scores
- pRec
- 0.231
Intolerance Scores
- loftool
- 0.378
- rvis_EVS
- -0.84
- rvis_percentile_EVS
- 11.18
Haploinsufficiency Scores
- pHI
- 0.903
- hipred
- Y
- hipred_score
- 0.518
- ghis
- 0.616
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.967
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sp4
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;positive regulation of nucleic acid-templated transcription
- Cellular component
- nucleus;nucleoplasm;cytosol
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;transcription coactivator activity;protein binding;sequence-specific DNA binding;metal ion binding